BSX

Q: What is the price of Boston Scientific (BSX) today?

The current price of Boston Scientific (BSX) is $ 60.99, representing a -35.88% gain over the past year. The stock began the year trading around $ 95.35 and is currently priced at $ 60.99. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Boston Scientific (BSX) pay dividends?

Boston Scientific (BSX) did not pay dividends over the past year.

Boston Scientific Corp.

Price

$ 60.99

return (12m)

-35.88%

p/e

32.87

p/bv

0.00

DIVIDEND YIELD

0.00%

BSX price

BSX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment BSX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-12.22%

3 months

-33.13%

1 year

-35.88%

2 years

-9.42%

5 years

43.27%

10 years

208.97%

Fundamentals BSX

review the fundamentals of Boston Scientific shares

P/E

32.87

Sector: -2.29 Industry: -5.62

P/S (PSR)

4.74

Sector: 1.99 Industry: 2.92

P/BV

0.00

Sector: 2.18 Industry: 2.12

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

0.00%

Sector: -26.05% Industry: -48.74%

ROE

0.00%

Sector: -29.81% Industry: -41.50%

ROIC

10.65%

Sector: -416.93% Industry: -485.80%

NET MARGIN

14.44%

Sector: -28.23% Industry: -32.27%

GROSS MARGIN

68.95%

Sector: 44.66% Industry: 45.26%

OPERATING MARGIN

19.78%

Sector: -23.34% Industry: -27.83%

EV/EBITDA

19.65

Sector: -0.62 Industry: -2.47

EV/EBIT

25.51

Sector: -1.80 Industry: -4.30

PRICE-TO-ASSETS

Sector: 1.17 Industry: 1.27

BVPS

Sector: 3.79 Industry: 2.16

EPS

1.95

Sector: -0.90 Industry: -1.33

EQUITY-TO-ASSETS RATIO

Sector: 0.43 Industry: 0.49

LIABILITIES / ASSETS

Sector: 0.46 Industry: 0.42

CAGR REVENUE 5 YEARS

11.05%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

22.72%

Sector: - Industry: -

Fundamentals BSX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	40.20	34.79	86.53%	0.67%	$ 829.69 B	31.66%
ISRG	58.32	9.28	15.92%	0.00%	$ 166.57 B	28.38%
TMO	29.53	3.70	12.52%	0.33%	$ 198.00 B	15.05%
SNY	12.86	1.40	10.86%	4.60%	$ 117.31 B	18.68%
NVS	20.81	6.25	30.04%	4.59%	$ 291.02 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	23.97	2.25	9.38%	3.30%	$ 110.58 B	13.00%
GSK	15.37	5.49	35.71%	3.00%	$ 117.24 B	17.48%
CVS	55.53	1.30	2.35%	3.44%	$ 98.17 B	0.44%
TMDX	20.70	8.33	40.22%	0.00%	$ 3.94 B	31.43%
HCA	16.40	-40.15	-244.82%	0.60%	$ 111.26 B	8.97%
IDXX	44.49	29.36	65.99%	0.00%	$ 47.14 B	24.62%
RMD	22.41	5.27	23.51%	1.02%	$ 33.31 B	27.53%
DHR	38.10	2.62	6.88%	0.66%	$ 137.69 B	14.71%
INMD	9.84	1.35	13.73%	0.00%	$ 922.95 M	25.32%
PHG	27.23	2.20	8.06%	2.98%	$ 28.25 B	5.07%
FMS	11.87	0.80	6.75%	3.36%	$ 13.40 B	5.02%
SYK	40.51	5.86	14.48%	0.99%	$ 131.49 B	12.92%
CI	10.79	0.00	0.00%	2.19%	$ 74.12 B	2.50%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

BSX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Boston Scientific

Boston Scientific Corp.

Average Investor10 user rating

4.0 (42 people)

United States

47 years

Founded: 1979

1992

Time since IPO - 34 years

36.000

Employees

Boston Scientific Corporation operates in the Healthcare sector, within the Medical Devices industry. The company develops and commercializes minimally invasive technologies used to treat cardiovascular, neurological, urological, gastrointestinal, and chronic pain conditions.

Its portfolio includes:

Coronary and peripheral stents.
Electrophysiology and ablation technologies.
Implantable cardiac devices.
Neuromodulation and spinal cord stimulators.
Endoscopy and urology systems.

Boston Scientific serves hospitals and healthcare providers globally, with the United States representing its largest market.

Performance is influenced by demographic aging, procedure volumes, reimbursement policies, regulatory approvals, competitive device innovation, and hospital capital spending trends.

The company invests in digital health integration, image-guided therapies, and next-generation implantable technologies to support minimally invasive treatment growth.

Boston Scientific Corporation shares trade on the New York Stock Exchange (NYSE) under the ticker BSX.

History and Development

Founded in 1979 in Massachusetts, Boston Scientific initially focused on catheter-based technologies for interventional medicine.

The company went public in 1992, supporting expansion and increased research investment. Growth accelerated through acquisitions that broadened its cardiovascular, electrophysiology, and neuromodulation capabilities.

In recent years, Boston Scientific has expanded its structural heart and neuromodulation franchises, strengthened global distribution, and navigated healthcare system changes while maintaining focus on innovation and procedural growth in minimally invasive therapies.

Additional Information

Boston Scientific Corp. (United States) is listed on the NYSE and has a market capitalization of $95.25 Billions, with shareholders equity totaling $-.

The company employs approximately 36.000 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Boston Scientific Corp. reported $20.08 Billions in revenue, generating net income of $2.90 Billions.

Key financial metrics include a P/E ratio of 32.87, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BSX.

Market cap

$ 95.25 Billions

Net worth

$ -

Assets

$ -

Total Shares Outstanding

1.48 Billion

1,483,000,000

Average Daily Trading Volume

$ 15.58 Millions

$ 15,581,605.28

Sector

Health

Industry

Medical Supplies and Equipment

BSX

revenue by Business Segment Boston Scientific

Revenue by Region Boston Scientific

BSX revenue and profits

Financial Results BSX

DRAG THE FRAME TO SEE MORE DATA

BSX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 76.58 23,05% (12M)

P/E

55.53

3.44%

ROE

2.35%

P/BV

1.30

CI - Cigna

$ 279.92 --11,99% (12M)

P/E

10.79

2.19%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 38.31 --33,96% (12M)

P/E

-2.81

0.00%

ROE

-33.28%

P/BV

0.94

HUM - Humana

$ 210.34 --12,83% (12M)

P/E

20.72

1.73%

ROE

6.70%

P/BV

1.39

HCA - HCA Healthcare

$ 478.13 51,57% (12M)

P/E

16.40

0.60%

ROE

-244.82%

P/BV

-40.15

LLY - Eli Lilly

$ 919.90 11,97% (12M)

P/E

40.20

0.67%

ROE

86.53%

P/BV

34.79

NVS - Novartis

$ 150.99 44,28% (12M)

P/E

20.81

4.59%

ROE

30.04%

P/BV

6.25

LBPSW - 4D pharma

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-300.00%

P/VP

0.00

CVS - CVS Health

$ 76.58 23,05% (12 M)

P/L

55.53

3.44%

ROE

2.35%

P/VP

1.30

CI - Cigna

$ 279.92 --11,99% (12 M)

P/L

10.79

2.19%

ROE

0.00%

P/VP

0.00

CNC - Centene

$ 38.31 --33,96% (12 M)

P/L

-2.81

0.00%

ROE

-33.28%

P/VP

0.94

HUM - Humana

$ 210.34 --12,83% (12 M)

P/L

20.72

1.73%

ROE

6.70%

P/VP

1.39

HCA - HCA Healthcare

$ 478.13 51,57% (12 M)

P/L

16.40

0.60%

ROE

-244.82%

P/VP

-40.15

LLY - Eli Lilly

$ 919.90 11,97% (12 M)

P/L

40.20

0.67%

ROE

86.53%

P/VP

34.79

NVS - Novartis

$ 150.99 44,28% (12 M)

P/L

20.81

4.59%

ROE

30.04%

P/VP

6.25

Frequently Asked Questions

What is the price of Boston Scientific (BSX) today?

The current price of Boston Scientific (BSX) is $ 60.99, representing a -35.88% gain over the past year. The stock began the year trading around $ 95.35 and is currently priced at $ 60.99. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Boston Scientific (BSX) pay dividends?

Boston Scientific (BSX) did not pay dividends over the past year.

Is Boston Scientific (BSX) a good investment?

Boston Scientific (BSX) is currently trading at $ 60.99 with a P/E ratio of 32.87%. This represents a 6,311% premium compared to its historical average P/E. Over the past year, the stock has gained -35.88 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -35.88%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Boston Scientific (BSX) stock?

You can buy Boston Scientific (BSX) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol BSX and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Boston Scientific (BSX) yield today?

Over the past month, Boston Scientific (BSX) has returned -12.22% — -35.88% over the past year, and 43.27% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Boston Scientific (BSX) today at the current price of $ 60.99 your total investment would be $ 6,099.00.

Based on historical performance, the investment would have grown to approximately:

$ 3,910.68 after 1 year
$ 8,738.04 after 5 years
$ 18,844.08 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

BSX

Boston Scientific Corp.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment BSX

review the fundamentals of Boston Scientific shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Boston Scientific

Boston Scientific Corp.

United States

47 years

1992

36.000

History and Development

Additional Information

PROFIT X PRICE BSX

Financial Results BSX

BSX cash flow

Asset, Revenue and Profit Growth - BSX

BSX balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

HCA - HCA Healthcare

LLY - Eli Lilly

NVS - Novartis

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

HCA - HCA Healthcare

LLY - Eli Lilly

NVS - Novartis

Frequently Asked Questions